• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NGM
    4.14 Up 0.03(0.73%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Net Income (33,353) (23,426) (33,363)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation1,082  795  985  
    Adjustments To Net Income(2,047)19,194  4,279  
    Changes In Accounts Receivables -   -   -  
    Changes In Liabilities(253)1,976  2,734  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities115  974  783  
    Total Cash Flow From Operating Activities (34,456) (487) (24,582)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(5,505)(3,287)(826)
    Investments(271)(3,633)15,781  
    Other Cash flows from Investing Activities -   -   -  
    Total Cash Flows From Investing Activities (5,776) (6,920) 14,955  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock1,869  49,700  53,420  
    Net Borrowings10,000  (1,387)(3,655)
    Other Cash Flows from Financing Activities -  (437) -  
    Total Cash Flows From Financing Activities 11,869   47,876   49,765  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents (28,363) 40,469   40,138  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.